Liver Disease
📧 Sign up to get email alerts when something new happens for Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage [Phase 4]
Phase 4 clinical trial comparing how different thromboplastin reagents affect prothrombin time in patients with isolated extrinsic pathway f…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Long-Term Outcomes of ABO-Incompatible Versus Compatible Living Donor Liver Transplantation
This clinical trial update reports long-term outcomes comparing ABO-incompatible versus ABO-compatible living donor liver transplantation.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
Observational registry study evaluating the AE05ML device for Hem-o-lok polymer clip delivery in laparoscopic procedures, with enrollment by…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine [Phase 1]
Phase 1 pharmacokinetic study of AZD2389 in healthy participants, evaluating administration alone and in combination with quinidine; the tri…
-
FDA approval · 2025-07-24FDA Approved: DOPTELET SPRINKLE — Original Application (AkaRx, Inc.)
FDA approved the original application for DOPTELET SPRINKLE (avatrombopag) from AkaRx, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-24FDA Approved: DOPTELET — Supplemental Application (AkaRx, Inc.)
FDA approved a supplemental application for DOPTELET (avatrombopag) by AkaRx, Inc.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants [Phase 1]
This Phase 1 AstraZeneca trial evaluates how multiple oral doses of AZD2389 alter the pharmacokinetics of midazolam, caffeine, and bupropion…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy [Phase 3]
A Phase 3 trial evaluating the use of Indocyanine Green cholangiography and methylene blue to detect postoperative biliary fistula after hep…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver Problems [Phase 1]
Phase 1 study evaluating how Avenciguat (BI-685509) is absorbed and processed in people with and without liver disease; the trial status is …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease [NA]
LiverPAL is evaluating inpatient palliative care for patients with advanced liver disease, and the trial status is recruiting.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Screening for Chronic Liver Diseases in General Population [NA]
A clinical trial at University Hospital, Montpellier is actively recruiting to screen for chronic liver diseases in the general population, …
-
CLINICAL_TRIALS other · 2025-07-02Clinical Trial Update: Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
Clinical trial update for the ELEGANCE study, which investigates early detection of hepatocellular carcinoma in a high-risk cohort, currentl…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Natural History of Advanced Chronic Liver Diseases
Clinical trial NCT07042308 in Hong Kong is currently recruiting to study the natural history of advanced chronic liver diseases, including c…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Comparing Portal Vein Assessment by Intraoperative Doppler and Transesophageal Echocardiography
A completed clinical trial evaluated comparing portal vein assessment methods—intraoperative Doppler and transesophageal echocardiography—in…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: RESTORE Declined Livers Study [NA]
Clinical trial update for the RESTORE Declined Livers Study; status is ACTIVE_NOT_RECRUITING with sponsor Washington University School of Me…
-
CLINICAL_TRIALS research · 2025-06-23Clinical Trial Update: Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk [NA]
A clinical trial evaluating a digital behavioral therapy to reduce the risk of Type 2 Diabetes and liver disease, currently not yet recruiti…
-
CLINICAL_TRIALS other · 2025-06-22Clinical Trial Update: Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease [Phase 4]
Phase 4 clinical trial update for a non-selective beta-blocker in compensated advanced chronic liver disease. The study targets portal hyper…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC) [NA]
This document notes an ongoing clinical trial at Mayo Clinic examining a digital clinic for alcohol-associated liver disease and alcohol use…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults [NA]
A clinical trial is evaluating Panax Ginseng C.A. Mey extract for improving liver function in adults with liver diseases; recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction [Phase 1, Phase 2]
A Phase 1/2 study evaluating the safety, tolerability, and pharmacodynamics of RTA 402 in patients with liver disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030) [Phase 1]
Phase 1 study of Enlicitide Decanoate in individuals with liver impairment and hepatic insufficiency has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders [NA]
This document reports completion of a clinical trial evaluating a culturally-based palliative care tele-consult program for rural Southern e…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections [NA]
A randomized prospective study comparing CUSA to radiofrequency ablation for liver resections has completed.
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: DEscripitive Patient Analysis to Enable Risk-based Quality Improvement Measures in a lArge iNternal mediCIne grouP Practice
This clinical trial update outlines a descriptive patient analysis intended to support risk-based quality improvement in a large internal me…
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease
The MELD ESAS Evolution study, evaluating the symptomatic burden in patients with advanced chronic liver disease, has completed.